Call us today: London office:0333 335 5470 / Hull office:08448 849041 | Follow us online:

Exciting cancer drug combination shrinks tumours and stops growth

cancer-389921_1920 (1)

An ”exciting” new cancer drug combination appears to shrink tumours and halt their growth for months, according to an early-stage clinical trial which could mean months of extra life for patients.

UK researchers have hailed the promising results from giving two chemotherapy drugs, vistusertib and paclitaxel, in tandem for late stage cancers which have become resistant to conventional treatments.

Though tests are in their early stages and set up to test safety rather than survival, the trial found over half of patients with ovarian cancer and 35 per cent of those with lung cancer saw their cancers shrink by at least a third.

The researchers developed the drug combination after noticing that ovarian cancer cells resistant to chemotherapy have high levels of a molecule called p-S6K, which may help them to grow quickly.

For the full story follow the link below

https://www.independent.co.uk/news/health/cancer-chemotherapy-drug-combination-ovarian-lung-cancer-advanced-survival-life-expectancy-a8501811.html

Back to Posts
Copyright © S3 Science 2020. All rights reserved.